Trial · NCT00322452
Trial comparisons15
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 15 of 15
Download this page as JSON| Comparison | Source |
|---|---|
| Gefitinib vs Carboplatin/Paclitaxel: Objective Tumour Response Rate According to RECIST | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Common Toxicity Criteria (CTC) Grade 3, 4, or 5 Thrombocytopenia | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Neurotoxicity | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Common Toxicity Criteria (CTC) Grade 3, 4, or 5 Leukopenia | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Rashes/Acnes | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Vomiting | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Common Toxicity Criteria (CTC) Grade 3, 4, or 5 Liver Transaminases | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Diarrhoea | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Common Toxicity Criteria (CTC) Grade 3, 4, or 5 Neutropenia | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Common Toxicity Criteria (CTC) Grade 3, 4, or 5 Anaemia | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Quality of Life (QoL) as Measured by the Trial Outcome Index (TOI) of the Functional Assessment of Cancer Therapy - Lung Cancer (FACT-L) Questionnaire | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Quality of Life (QoL) as Measured by the Total Score of the Functional Assessment of Cancer Therapy - Lung Cancer (FACT-L) Questionnaire | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Nausea | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: Symptom Improvement as Measured by the Lung Cancer Subscale (LCS) of the FACT-L Questionnaire | Trial comparisons |
| Gefitinib vs Carboplatin/Paclitaxel: serious adverse events | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00322452/comparisons